Secondary outcomes
1. Ability to ingest a partial serving of cow’s milk without adverse
reactions (the dose varies according to the different definitions in
each study).
2. Side effects during OIT.
3. Change in skin-prick test(SPT) size, specific IgE level, specific
IgG4 level Data was analyzed on an intention-to-treat (ITT) basis
whenever possible.
4. Subgroup of the effect of adjuvant treatments such as OIT with baked
milk or omalizumab was analyzed if possible.